logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > Crisaborole CAS 906673-24-3 Improve Skin Conditions

Crisaborole CAS 906673-24-3 Improve Skin Conditions

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 906673-24-3

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Bag,Drum

Delivery Time: 7-15 days

Payment Terms: T/T, L/C, D/A, Western Union

Supply Ability: TON

Get Best Price
Highlight:

CAS 906673-24-3 Crisaborole

,

Crisaborole for Improve Skin Conditions

CAS No::
906673-24-3
Appearance::
White To Beige Powder
Molecular Formula::
C14H10BNO3
Molecular Weight::
251.05
EINECS NO::
N/A
MDL NO.::
MFCD17169940
CAS No::
906673-24-3
Appearance::
White To Beige Powder
Molecular Formula::
C14H10BNO3
Molecular Weight::
251.05
EINECS NO::
N/A
MDL NO.::
MFCD17169940
Crisaborole CAS 906673-24-3 Improve Skin Conditions

Product Description:

Product Name:Crisaborole CAS 906673-24-3

 

 

Synonyms:

[(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]benzonitrile AN 2728;

AN2728, Crisaborole;

Crisaborole (AN2728);

 

 

Chemical & Physical Properties

Appearance:White to beige powder

Assay: 99%+

Boiling point:425.9±55.0℃

Melting pointL:>130℃

Solubility:DMSO (Slightly), Methanol (Slightly)

Stability:Hygroscopic

Density:1.33±0.1g/cm3

Pka:7.00±0.20

 

 

Application

AN2728 has shown effective activity in vivo and in vitro, and the anti-inflammatory activity of AN2728 is being investigated. It is also used as a pharmaceutical intermediate.The biggest advantage of Creborol is that it is a small-molecule non-hormone drug, which can achieve both therapeutic effect and comfort, and even have few side effects for some patients. It is the first non-dermatologic drug to enter the clinical urgently needed new drug name Chemicalbook. It can be said that the listing of Creborol fills the treatment needs of children and adults with atopic dermatitis in China, breaking the status quo of no new products in the field of topical non-hormonal anti-inflammatory for more than 10 years, and has epoch-making significance.

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.